Abbott Laboratories
€10,000 invested in 2016 · with dividend reinvestment
Dividend history
Quarterly Results
About Abbott Laboratories
Abbott Laboratories is a broad healthcare company spanning medical devices, diagnostics, nutrition and established pharmaceuticals. Its cardiovascular devices and continuous glucose monitors, led by the FreeStyle Libre, are among the strongest franchises in medtech, while the diagnostics arm gained global scale during the pandemic. That diversification gives Abbott a resilient, recession-resistant earnings base. Abbott is a stalwart for income investors, having paid and raised its dividend for decades through the parent company and its Abbott heritage. A well-covered payout, backed by durable cash flows across several defensive healthcare markets, underpins one of the stronger dividend profiles in the group. The yield is modest, but the reliability and consistent growth are what stand out.